Horizon Therapeutics Public Limited Company (HZNP) — Analyst outlook / Analyst consensus target is. Based on 25 analyst ratings, the consensus is bullish — 15 Buy, 10 Hold.
The consensus price target is $127.15 (low: $110.00, high: $144.00), representing an upside of 9.3% from the current price $116.30.
HZNP Stock — 12-Month Price Forecast
$127.15
▲ +9.33% Upside
Average Price Target
Based on 25 Wall Street analysts offering 12-month price targets for Horizon Therapeutics Public Limited Company, the average price target is $127.15, with a high forecast of $144.00, and a low forecast of $110.00.
The average price target represents a +9.33% change from the last price of $116.30.
Highest Price Target
$144.00
Average Price Target
$127.15
Lowest Price Target
$110.00
HZNP Analyst Ratings
Buy
Based on 25 analysts giving stock ratings to Horizon Therapeutics Public Limited Company in the past 3 months
